A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Stopped Monotherapy arm completed. Combination arm did not proceed (sponsor decision).

Conditions

• Colorectal Cancer

Interventions

• DRUG: BNC101 Solution for Infusion
• DRUG: BNC101 in combination with FOLFIRI

Sponsor

Bionomics Limited

Collaborators

• [object Object]